Correlation Between Ultimovacs ASA and Exact Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ultimovacs ASA and Exact Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ultimovacs ASA and Exact Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ultimovacs ASA and Exact Therapeutics AS, you can compare the effects of market volatilities on Ultimovacs ASA and Exact Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ultimovacs ASA with a short position of Exact Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ultimovacs ASA and Exact Therapeutics.

Diversification Opportunities for Ultimovacs ASA and Exact Therapeutics

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Ultimovacs and Exact is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Ultimovacs ASA and Exact Therapeutics AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exact Therapeutics and Ultimovacs ASA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ultimovacs ASA are associated (or correlated) with Exact Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exact Therapeutics has no effect on the direction of Ultimovacs ASA i.e., Ultimovacs ASA and Exact Therapeutics go up and down completely randomly.

Pair Corralation between Ultimovacs ASA and Exact Therapeutics

If you would invest (100.00) in Ultimovacs ASA on November 2, 2024 and sell it today you would earn a total of  100.00  from holding Ultimovacs ASA or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy0.0%
ValuesDaily Returns

Ultimovacs ASA  vs.  Exact Therapeutics AS

 Performance 
       Timeline  
Ultimovacs ASA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days Ultimovacs ASA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite weak essential indicators, Ultimovacs ASA disclosed solid returns over the last few months and may actually be approaching a breakup point.
Exact Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Exact Therapeutics AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in March 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Ultimovacs ASA and Exact Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ultimovacs ASA and Exact Therapeutics

The main advantage of trading using opposite Ultimovacs ASA and Exact Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ultimovacs ASA position performs unexpectedly, Exact Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exact Therapeutics will offset losses from the drop in Exact Therapeutics' long position.
The idea behind Ultimovacs ASA and Exact Therapeutics AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Money Managers
Screen money managers from public funds and ETFs managed around the world